Document is current
Any future updates will be listed below
-
Authors
Vora, Shivam https://orcid.org/0000-0002-8256-3215
Andrew, Ariel
Kumar, Ramyashree Prasanna
Nazareth, Deborah https://orcid.org/0000-0002-5983-3571
Bonfim-Melo, Alexis
Lim, Yoon https://orcid.org/0000-0003-1110-1969
Ong, Xin Yee https://orcid.org/0009-0005-8328-1219
Fernando, Madushan
He, Yaowu
Hooper, John D. https://orcid.org/0000-0003-1054-8486
McMillan, Nigel AJ https://orcid.org/0000-0002-9471-1406
Urosevic, Jelena
Travers, Jon
Saeh, Jamal
Kumar, Sharad https://orcid.org/0000-0001-7126-9814
Jones, Mathew JK https://orcid.org/0000-0003-2714-8411
Gabrielli, Brian https://orcid.org/0000-0003-3933-1651
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1104186)
AstraZeneca
- License Information
-
More Information
Article History
Received: 26 July 2024
Revised: 27 October 2024
Accepted: 30 October 2024
First Online: 9 November 2024
Competing interests
: JT, JS and JU are current or former employees and shareholders of AstraZeneca. Other authors declare no conflict of interest
: This research did not use either patients, patient derived materials or data, or animal models. Therefore these approvals and consents were not required for this study.
